Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Malaria Journal|September 9, 2016
Field evaluation of diagnostic performance of malaria rapid diagnostic tests in western KenyaElizabeth W Wanja, Nickline Kuya, Collins Moranga, et al.
Anti-Cancer Drugs|February 12, 2009
Selective cytotoxic activity of the marine-derived batzelline compounds against pancreatic cancer cell linesEsther A Guzmán, Jacob D Johnson, Megan K Carrier, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2011
Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallizationRebecca D Sandlin, Melissa D Carter, Patricia J Lee, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2015
Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from KenyaLuicer A Ingasia, Hoseah M Akala, Mabel O Imbuga, et al.
Journal of Lipid Research|March 25, 2008
An analysis of the role of a retroendocytosis pathway in ABCA1-mediated cholesterol efflux from macrophagesLoren E Faulkner, Stacey E Panagotopulos, Jacob D Johnson, et al.
Acta Tropica|May 12, 2012
The antiplasmodial and radical scavenging activities of flavonoids of Erythrina burttiiAbiy Yenesew, Hoseah M Akala, Hannington Twinomuhwezi, et al.
Malaria Journal|July 16, 2013
Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from CambodiaSuwanna Chaorattanakawee, Stuart D Tyner, Chanthap Lon, et al.
The American Journal of Tropical Medicine and Hygiene|July 8, 2011
Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysisHoseah M Akala, Fredrick L Eyase, Agnes C Cheruiyot, et al.
Malaria Journal|December 18, 2013
A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugsNeils B Quashie, Nancy O Duah, Benjamin Abuaku, et al.
Malaria Journal|January 30, 2014
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre studyBernhards R Ogutu, Kevin O Onyango, Nelly Koskei, et al.
Pageof 3